Medicamen Biotech Dividend
Dividend criteria checks 1/6
Medicamen Biotech is a dividend paying company with a current yield of 0.22% that is well covered by earnings.
Key information
0.2%
Dividend yield
13%
Payout ratio
| Industry average yield | 0.8% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Earnings per share | ₹8.60 |
| Dividend yield forecast in 3Y | n/a |
Recent dividend updates
Recent updates
What Medicamen Biotech Limited's (NSE:MEDICAMEQ) 28% Share Price Gain Is Not Telling You
May 21
More Unpleasant Surprises Could Be In Store For Medicamen Biotech Limited's (NSE:MEDICAMEQ) Shares After Tumbling 26%
Mar 17Medicamen Biotech (NSE:MEDICAMEQ) Will Pay A Dividend Of ₹1.00
Sep 13Why Medicamen Biotech's (NSE:MEDICAMEQ) Shaky Earnings Are Just The Beginning Of Its Problems
Nov 19There's Reason For Concern Over Medicamen Biotech Limited's (NSE:MEDICAMEQ) Price
Dec 03Stability and Growth of Payments
Fetching dividends data
Stable Dividend: MEDICAMEQ has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: MEDICAMEQ has only been paying a dividend for 7 years, and since then payments have not increased.
Dividend Yield vs Market
| Medicamen Biotech Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (MEDICAMEQ) | 0.2% |
| Market Bottom 25% (IN) | 0.3% |
| Market Top 25% (IN) | 1.1% |
| Industry Average (Pharmaceuticals) | 0.8% |
| Analyst forecast in 3 Years (MEDICAMEQ) | n/a |
Notable Dividend: MEDICAMEQ's dividend (0.22%) isn’t notable compared to the bottom 25% of dividend payers in the Indian market (0.27%).
High Dividend: MEDICAMEQ's dividend (0.22%) is low compared to the top 25% of dividend payers in the Indian market (1.12%).
Earnings Payout to Shareholders
Earnings Coverage: With its low payout ratio (13.3%), MEDICAMEQ's dividend payments are thoroughly covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: MEDICAMEQ is paying a dividend but the company has no free cash flows.